Skip to content

Brief Intervention for Teen Pregnancy Prevention

Prevention of Teen Pregnancy Through Screening and Brief Intervention in Primary Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02816424
Acronym
TEMPO
Enrollment
447
Registered
2016-06-28
Start date
2015-11-11
Completion date
2021-08-20
Last updated
2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Teen Pregnancy Prevention

Keywords

Screening and Brief Intervention, Motivational Interviewing, Teen Pregnancy Prevention

Brief summary

Although the Academy of Pediatrics and the Society for Adolescent Health and Medicine recommend that teen health providers screen for sexual risk behaviors and provide education and counseling to those at risk, there are currently no specific guidelines or protocols available to guide such practices, nor have there been any rigorous evaluations of efficacy. Preventing teen pregnancy through brief intervention in primary care holds the promise to have a significant public health impact and reduce health disparities by engaging, educating, and motivating the majority of teens who visit a primary care setting each year. In the current study, we seek to rigorously evaluate the impact of brief intervention vs. informational control on unprotected sexual intercourse among teens with past year unprotected sex at two primary care clinics serving predominately underserved, minority populations in New Mexico. The target population for the current study will be 1350 male and female teens, aged 13-19, from the Atrisco Center for Family and Community Health and the Albuquerque Job Corps Wellness Center. Extensive formative work involving the study population will be conducted prior to the trial to refine the motivational interviewing-based brief intervention. Eligible youth will be randomly assigned to brief intervention or an informational control condition, in addition to regularly offered medically-based contraception consultation and prescription services. Follow-ups at 3- and 9- months will compare rates of unprotected sex and acceptance of long-acting reversible contraceptives. Brief education and counseling interventions could be feasibly implemented during the greater than eight preventive and acute primary care visits that the average US adolescent attends during their teen years. Such an approach could conserve valuable resources required by more intensive interventions for nonresponsive teens with greater need. Furthermore, social determinants of health, such as poverty and race, that may reduce access to more extensive psychosocial interventions, are less likely to prevent access to primary care, increasing health equity.

Interventions

BEHAVIORALTeens Exploring and Managing Prevention Options (TEMPO)

Sponsors

Department of Health and Human Services
CollaboratorFED
University of New Mexico
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
13 Years to 19 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 13-19 * Self-reported past year unprotected sex * Can read and speak English * Willing to be contacted for follow-up

Exclusion criteria

* Current use of long-acting reversible contraceptives * Self-reported pregnancy or pregnancy discovered during optional medical contraception consultation * Expressed suicidality * Obvious cognitive impairment * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants endorsing unprotected sex at 3 month follow up3-Month EndpointAll participants
Proportion of participants endorsing acceptance of Long Acting Reversible Contraception (LARC) at 3 month follow up3-Month EndpointAmong female participants

Secondary

MeasureTime frameDescription
Proportion of participants endorsing unprotected sex at 9 month follow up9-Month EndpointAll participants
Proportion of participants endorsing acceptance of Long Acting Reversible Contraception (LARC) at 9 month follow up9-Month EndpointAmong female participants

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026